Cargando…

Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR), as an alternative to open heart surgery, has revolutionized the treatment of severe aortic valve stenosis (AVS), the most common valvular disorder in the elderly. AVS is now considered a form of atherosclerosis and, like the latter, partly of inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales: Lassalle, Fanny, Rosa, Mickael, Staels, Bart, Van Belle, Eric, Susen, Sophie, Dupont, Annabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141814/
https://www.ncbi.nlm.nih.gov/pubmed/35628113
http://dx.doi.org/10.3390/ijms23105303
_version_ 1784715434972413952
author Lassalle, Fanny
Rosa, Mickael
Staels, Bart
Van Belle, Eric
Susen, Sophie
Dupont, Annabelle
author_facet Lassalle, Fanny
Rosa, Mickael
Staels, Bart
Van Belle, Eric
Susen, Sophie
Dupont, Annabelle
author_sort Lassalle, Fanny
collection PubMed
description Transcatheter aortic valve replacement (TAVR), as an alternative to open heart surgery, has revolutionized the treatment of severe aortic valve stenosis (AVS), the most common valvular disorder in the elderly. AVS is now considered a form of atherosclerosis and, like the latter, partly of inflammatory origin. Patients with high-grade AVS have a highly disturbed blood flow associated with high levels of shear stress. The immediate reopening of the valve during TAVR leads to a sudden restoration of a normal blood flow hemodynamic. Despite its good prognosis for patients, TAVR remains associated with bleeding or thrombotic postprocedural complications, involving mechanisms that are still poorly understood. Many studies report the close link between blood coagulation and inflammation, termed thromboinflammation, including monocytes as a major actor. The TAVR procedure represents a unique opportunity to study the influence of shear stress on human monocytes, key mediators of inflammation and hemostasis processes. The purpose of this study was to conduct a review of the literature to provide a comprehensive overview of the impact of TAVR on monocyte phenotype and subset repartition and the association of these parameters with the clinical outcomes of patients with severe AVS who underwent TAVR.
format Online
Article
Text
id pubmed-9141814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91418142022-05-28 Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement Lassalle, Fanny Rosa, Mickael Staels, Bart Van Belle, Eric Susen, Sophie Dupont, Annabelle Int J Mol Sci Review Transcatheter aortic valve replacement (TAVR), as an alternative to open heart surgery, has revolutionized the treatment of severe aortic valve stenosis (AVS), the most common valvular disorder in the elderly. AVS is now considered a form of atherosclerosis and, like the latter, partly of inflammatory origin. Patients with high-grade AVS have a highly disturbed blood flow associated with high levels of shear stress. The immediate reopening of the valve during TAVR leads to a sudden restoration of a normal blood flow hemodynamic. Despite its good prognosis for patients, TAVR remains associated with bleeding or thrombotic postprocedural complications, involving mechanisms that are still poorly understood. Many studies report the close link between blood coagulation and inflammation, termed thromboinflammation, including monocytes as a major actor. The TAVR procedure represents a unique opportunity to study the influence of shear stress on human monocytes, key mediators of inflammation and hemostasis processes. The purpose of this study was to conduct a review of the literature to provide a comprehensive overview of the impact of TAVR on monocyte phenotype and subset repartition and the association of these parameters with the clinical outcomes of patients with severe AVS who underwent TAVR. MDPI 2022-05-10 /pmc/articles/PMC9141814/ /pubmed/35628113 http://dx.doi.org/10.3390/ijms23105303 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lassalle, Fanny
Rosa, Mickael
Staels, Bart
Van Belle, Eric
Susen, Sophie
Dupont, Annabelle
Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement
title Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement
title_full Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement
title_fullStr Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement
title_full_unstemmed Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement
title_short Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement
title_sort circulating monocyte subsets and transcatheter aortic valve replacement
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141814/
https://www.ncbi.nlm.nih.gov/pubmed/35628113
http://dx.doi.org/10.3390/ijms23105303
work_keys_str_mv AT lassallefanny circulatingmonocytesubsetsandtranscatheteraorticvalvereplacement
AT rosamickael circulatingmonocytesubsetsandtranscatheteraorticvalvereplacement
AT staelsbart circulatingmonocytesubsetsandtranscatheteraorticvalvereplacement
AT vanbelleeric circulatingmonocytesubsetsandtranscatheteraorticvalvereplacement
AT susensophie circulatingmonocytesubsetsandtranscatheteraorticvalvereplacement
AT dupontannabelle circulatingmonocytesubsetsandtranscatheteraorticvalvereplacement